| Potency | 70794.6 nM | Thyroid hormone receptor beta-1 | P10828 | |
| Potency | 11220.2 nM | Nuclear factor NF-kappa-B p105 subunit | P19838 | |
| Potency | 25118.9 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
| Potency | 46109.1 nM | Ras-related protein Rab-9A | P51151 | |
| Potency | 7079.5 nM | Survival motor neuron protein | Q16637 | |
| Potency | 25118.9 nM | Thyroid stimulating hormone receptor | P16473 | |
| Potency | 63095.7 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
| Potency | 10000 nM | Cytochrome P450 2C19 | P33261 | |
| Potency | 15848.9 nM | Microtubule-associated protein tau | P10636 | |
| Potency | 15848.9 nM | Microtubule-associated protein tau | P10636 | |
| Potency | 31622.8 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
| Potency | 22387.2 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
| Potency | 15848.9 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
| Potency | 19952.6 nM | Arachidonate 15-lipoxygenase | P16050 | |
| Potency | 501.2 nM | Microtubule-associated protein tau | P10636 | |
| Potency | 31622.8 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
| Potency | 31622.8 nM | MAP kinase ERK2 | P28482 | |
| Potency | 12589.3 nM | Arachidonate 12-lipoxygenase | P18054 | |
| Potency | 11220.2 nM | Nuclear factor NF-kappa-B p105 subunit | P19838 | |
| Potency | 25118.9 nM | Thyroid stimulating hormone receptor | P16473 | |
| Potency | 58047.9 nM | Niemann-Pick C1 protein | O15118 | |
| Potency | 25118.9 nM | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | |
| Potency | 2930.9 nM | Serine/threonine-protein kinase mTOR | P42345 | |
| Potency | 19952.6 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
| Potency | 1995.3 nM | Thrombopoietin | P40225 | |
| Potency | 19952.6 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
| Potency | 5011.9 nM | Cellular tumor antigen p53 | P04637 | |
| Potency | 12589.3 nM | Cellular tumor antigen p53 | P04637 | |
| Potency | 25118.9 nM | Cytochrome P450 2D6 | P10635 | |
| Potency | 31622.8 nM | Cytochrome P450 3A4 | P08684 | |
| Potency | 31622.8 nM | Cytochrome P450 3A4 | P08684 | |
| Potency | 39810.7 nM | Cytochrome P450 2C9 | P11712 | |
| Potency | 1995.3 nM | Thrombopoietin | P40225 | |
| Potency | 16353.5 nM | ATPase family AAA domain-containing protein 5 | Q96QE3 | |
| Potency | 16360.1 nM | Nuclear factor erythroid 2-related factor 2 | Q16236 | |
| Potency | 31622.8 nM | Histone acetyltransferase GCN5 | Q92830 | |
| Potency | 16833.6 nM | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Q96KQ7 | |
| Potency | 50118.7 nM | Chromobox protein homolog 1 | P83916 | |
| Potency | 15848.9 nM | Arachidonate 15-lipoxygenase, type II | O15296 | |
| Potency | 12589.3 nM | Arachidonate 15-lipoxygenase, type II | O15296 | |
| Potency | 29934.9 nM | Flap endonuclease 1 | P39748 | |
| Potency | 5623.4 nM | Ataxin-2 | Q99700 | |
| Others | 13.1 % | Solute carrier organic anion transporter family member 2B1 | O94956 | |
| Others | 24.9 % | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | |
| Others | -0.7 % | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | |
| Others | 91 % | Serine/threonine-protein kinase MARK1 | Q9P0L2 | |
| Others | 110 % | Serine/threonine-protein kinase SRPK3 | Q9UPE1 | |
| Others | 66 % | Serine/threonine-protein kinase SRPK3 | Q9UPE1 | |
| Others | 100 % | Serine/threonine-protein kinase NEK7 | Q8TDX7 | |
| Others | 137 % | Serine/threonine-protein kinase NEK7 | Q8TDX7 | |
| Others | 82 % | Tyrosine-protein kinase ABL2 | P42684 | |
| Others | 83 % | Serine/threonine-protein kinase Aurora-A | O14965 | |
| Others | 96 % | Casein kinase I delta | P48730 | |
| Others | 94 % | Death-associated protein kinase 1 | P53355 | |
| Others | 107 % | Ephrin type-A receptor 5 | P54756 | |
| Others | 57 % | Fibroblast growth factor receptor 3 | P22607 | |
| Others | 115 % | Fibroblast growth factor receptor 4 | P22455 | |
| Others | 63 % | Tyrosine-protein kinase FYN | P06241 | |
| Others | 92 % | Tyrosine-protein kinase HCK | P08631 | |
| Others | 83 % | Inhibitor of nuclear factor kappa B kinase alpha subunit | O15111 | |
| Others | 101 % | Inhibitor of nuclear factor kappa B kinase beta subunit | O14920 | |
| Others | 63 % | c-Jun N-terminal kinase 3 | P53779 | |
| Others | 125 % | Dual specificity mitogen-activated protein kinase kinase 1 | Q02750 | |
| Others | 119 % | Dual specificity mitogen-activated protein kinase kinase 1 | Q02750 | |
| Others | 92 % | Serine/threonine-protein kinase MST1 | Q13043 | |
| Others | 92 % | Serine/threonine protein kinase NLK | Q9UBE8 | |
| Others | 75 % | Serine/threonine-protein kinase Aurora-A | O14965 | |
| Others | 103 % | Casein kinase I delta | P48730 | |
| Others | 71 % | Death-associated protein kinase 1 | P53355 | |
| Others | 99 % | Death-associated protein kinase 2 | Q9UIK4 | |
| Others | 99 % | Ephrin type-A receptor 5 | P54756 | |
| Others | 94 % | Ephrin type-A receptor 7 | Q15375 | |
| Others | 100 % | Fibroblast growth factor receptor 4 | P22455 | |
| Others | 103 % | Mitogen-activated protein kinase kinase kinase kinase 2 | Q12851 | |
| Others | 72 % | Mitogen-activated protein kinase kinase kinase kinase 2 | Q12851 | |
| Others | 138 % | Insulin-like growth factor I receptor | P08069 | |
| Others | 131 % | Insulin-like growth factor I receptor | P08069 | |
| Others | 84 % | Inhibitor of nuclear factor kappa B kinase beta subunit | O14920 | |
| Others | 101 % | Vascular endothelial growth factor receptor 2 | P35968 | |
| Others | 90 % | Vascular endothelial growth factor receptor 2 | P35968 | |
| Others | 84 % | Maternal embryonic leucine zipper kinase | Q14680 | |
| Others | 98 % | Serine/threonine-protein kinase MST1 | Q13043 | |
| Others | 107 % | Serine/threonine-protein kinase MST2 | Q13188 | |
| Others | 76 % | Serine/threonine protein kinase NLK | Q9UBE8 | |
| Others | 102 % | Serine/threonine-protein kinase PAK 2 | Q13177 | |
| Others | 130 % | Serine/threonine-protein kinase Aurora-B | Q96GD4 | |
| Others | 60 % | Serine/threonine-protein kinase Aurora-B | Q96GD4 | |
| Others | 91 % | Death-associated protein kinase 2 | Q9UIK4 | |
| Others | 79 % | Ephrin type-A receptor 7 | Q15375 | |
| Others | 115 % | Tyrosine-protein kinase FER | P16591 | |
| Others | 80 % | Tyrosine-protein kinase FER | P16591 | |
| Others | 103 % | G protein-coupled receptor kinase 5 | P34947 | |
| Others | 93 % | Insulin-like growth factor I receptor | P08069 | |
| Others | 117 % | Insulin receptor | P06213 | |
| Others | 130 % | Insulin receptor | P06213 | |
| Others | 108 % | LIM domain kinase 1 | P53667 | |
| Others | 31 % | Maternal embryonic leucine zipper kinase | Q14680 | |
| Others | 97 % | Misshapen-like kinase 1 | Q8N4C8 | |
| Others | 94 % | Serine/threonine-protein kinase MST2 | Q13188 | |
| Others | 81 % | Serine/threonine-protein kinase PAK 2 | Q13177 | |
| Others | 104 % | Serine/threonine-protein kinase Aurora-C | Q9UQB9 | |
| Others | 126 % | Casein kinase II alpha (prime) | P19784 | |
| Others | 101 % | Casein kinase II alpha (prime) | P19784 | |
| Others | 98 % | Serine/threonine-protein kinase DCLK2 | Q8N568 | |
| Others | 90 % | Serine/threonine-protein kinase DCLK2 | Q8N568 | |
| Others | 108 % | Ephrin type-A receptor 8 | P29322 | |
| Others | 101 % | Ephrin type-A receptor 8 | P29322 | |
| Others | 82 % | G protein-coupled receptor kinase 5 | P34947 | |
| Others | 96 % | G protein-coupled receptor kinase 6 | P43250 | |
| Others | 99 % | Insulin receptor | P06213 | |
| Others | 87 % | LIM domain kinase 1 | P53667 | |
| Others | 102 % | Serine/threonine-protein kinase 11 | Q15831 | |
| Others | 75 % | Misshapen-like kinase 1 | Q8N4C8 | |
| Others | 73 % | Serine/threonine-protein kinase 24 | Q9Y6E0 | |
| Others | 73 % | Serine/threonine-protein kinase 24 | Q9Y6E0 | |
| Others | 72 % | Serine/threonine-protein kinase PAK 3 | O75914 | |
| Others | 83 % | Serine/threonine-protein kinase PAK 3 | O75914 | |
| Others | 90 % | Serine/threonine-protein kinase Aurora-C | Q9UQB9 | |
| Others | 93 % | Tyrosine-protein kinase receptor UFO | P30530 | |
| Others | 120 % | Dual specificity protein kinase CLK2 | P49760 | |
| Others | 102 % | Discoidin domain-containing receptor 2 | Q16832 | |
| Others | 89 % | Ephrin type-B receptor 1 | P54762 | |
| Others | 93 % | G protein-coupled receptor kinase 6 | P43250 | |
| Others | 84 % | Insulin receptor | P06213 | |
| Others | 90 % | Serine/threonine-protein kinase 11 | Q15831 | |
| Others | 102 % | Dual specificity mitogen-activated protein kinase kinase 6 | P52564 | |
| Others | 130 % | Dual specificity mitogen-activated protein kinase kinase 6 | P52564 | |
| Others | 102 % | Proto-oncogene tyrosine-protein kinase MER | Q12866 | |
| Others | 84 % | Tyrosine kinase non-receptor protein 2 | Q07912 | |
| Others | 68 % | Tyrosine kinase non-receptor protein 2 | Q07912 | |
| Others | 44 % | Tyrosine-protein kinase receptor UFO | P30530 | |
| Others | 93 % | Dual specificity protein kinase CLK2 | P49760 | |
| Others | 74 % | Dual specificity protein kinase CLK3 | P49761 | |
| Others | 94 % | Discoidin domain-containing receptor 2 | Q16832 | |
| Others | 111 % | Myotonin-protein kinase | Q09013 | |
| Others | 91 % | Ephrin type-B receptor 1 | P54762 | |
| Others | 121 % | Ephrin type-B receptor 2 | P29323 | |
| Others | 99 % | G protein-coupled receptor kinase 7 | Q8WTQ7 | |
| Others | 91 % | G protein-coupled receptor kinase 7 | Q8WTQ7 | |
| Others | 96 % | Interleukin-1 receptor-associated kinase 1 | P51617 | |
| Others | 83 % | Interleukin-1 receptor-associated kinase 1 | P51617 | |
| Others | 100 % | Serine/threonine-protein kinase 10 | O94804 | |
| Others | 93 % | Serine/threonine-protein kinase 10 | O94804 | |
| Others | 110 % | Dual specificity mitogen-activated protein kinase kinase 7 | O14733 | |
| Others | 96 % | Proto-oncogene tyrosine-protein kinase MER | Q12866 | |
| Others | 94 % | Hepatocyte growth factor receptor | P08581 | |
| Others | 92 % | ALK tyrosine kinase receptor | Q9UM73 | |
| Others | 110 % | Tyrosine-protein kinase BRK | Q13882 | |
| Others | 101 % | Tyrosine-protein kinase BRK | Q13882 | |
| Others | 80 % | Dual specificity protein kinase CLK3 | P49761 | |
| Others | 126 % | Myotonin-protein kinase | Q09013 | |
| Others | 121 % | Ephrin type-B receptor 2 | P29323 | |
| Others | 126 % | Glycogen synthase kinase-3 alpha | P49840 | |
| Others | 107 % | Interleukin-1 receptor-associated kinase 4 | Q9NWZ3 | |
| Others | 114 % | Tyrosine-protein kinase LCK | P06239 | |
| Others | 71 % | Dual specificity mitogen-activated protein kinase kinase 7 | O14733 | |
| Others | 78 % | Myosin light chain kinase, smooth muscle | Q15746 | |
| Others | 85 % | Hepatocyte growth factor receptor | P08581 | |
| Others | 65 % | ALK tyrosine kinase receptor | Q9UM73 | |
| Others | 132 % | Activin receptor type-1B | P36896 | |
| Others | 93 % | Tyrosine-protein kinase BTK | Q06187 | |
| Others | 115 % | Tyrosine-protein kinase CSK | P41240 | |
| Others | 95 % | Tyrosine-protein kinase CSK | P41240 | |
| Others | 102 % | Serine/threonine-protein kinase 17A | Q9UEE5 | |
| Others | 77 % | Serine/threonine-protein kinase 17A | Q9UEE5 | |
| Others | 126 % | Ephrin type-B receptor 3 | P54753 | |
| Others | 133 % | Ephrin type-B receptor 3 | P54753 | |
| Others | 121 % | Tyrosine-protein kinase FES | P07332 | |
| Others | 103 % | Glycogen synthase kinase-3 alpha | P49840 | |
| Others | 97 % | Glycogen synthase kinase-3 beta | P49841 | |
| Others | 83 % | Interleukin-1 receptor-associated kinase 4 | Q9NWZ3 | |
| Others | 130 % | Insulin receptor-related protein | P14616 | |
| Others | 107 % | Tyrosine-protein kinase LCK | P06239 | |
| Others | 80 % | Tyrosine-protein kinase LCK | P06239 | |
| Others | 107 % | Myosin light chain kinase, smooth muscle | Q15746 | |
| Others | 101 % | MAP kinase signal-integrating kinase 2 | Q9HBH9 | |
| Others | 82 % | MAP kinase signal-integrating kinase 2 | Q9HBH9 | |
| Others | 94 % | Activin receptor type-1B | P36896 | |
| Others | 102 % | Tyrosine-protein kinase BTK | Q06187 | |
| Others | 114 % | Tyrosine-protein kinase BLK | P51451 | |
| Others | 109 % | CaM kinase I alpha | Q14012 | |
| Others | 107 % | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | Q92630 | |
| Others | 94 % | Ephrin type-B receptor 4 | P54760 | |
| Others | 76 % | Tyrosine-protein kinase FES | P07332 | |
| Others | 83 % | Glycogen synthase kinase-3 beta | P49841 | |
| Others | 76 % | Insulin receptor-related protein | P14616 | |
| Others | 79 % | Tyrosine-protein kinase LCK | P06239 | |
| Others | 101 % | Mitogen-activated protein kinase kinase kinase 9 | P80192 | |
| Others | 114 % | Muscle, skeletal receptor tyrosine protein kinase | O15146 | |
| Others | 90 % | Tyrosine-protein kinase BLK | P51451 | |
| Others | 86 % | Serine/threonine-protein kinase Chk1 | O14757 | |
| Others | 86 % | CaM kinase I alpha | Q14012 | |
| Others | 80 % | CaM kinase II beta | Q13554 | |
| Others | 96 % | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | Q92630 | |
| Others | 117 % | Epidermal growth factor receptor erbB1 | P00533 | |
| Others | 119 % | Ephrin type-B receptor 4 | P54760 | |
| Others | 116 % | Tyrosine-protein kinase FGR | P09769 | |
| Others | 77 % | Tyrosine-protein kinase FGR | P09769 | |
| Others | 95 % | Homeodomain-interacting protein kinase 1 | Q86Z02 | |
| Others | 103 % | Homeodomain-interacting protein kinase 1 | Q86Z02 | |
| Others | 99 % | Tyrosine-protein kinase ITK/TSK | Q08881 | |
| Others | 91 % | Tyrosine-protein kinase ITK/TSK | Q08881 | |
| Others | 83 % | Tyrosine-protein kinase Lyn | P07948 | |
| Others | 65 % | Tyrosine-protein kinase Lyn | P07948 | |
| Others | 81 % | Mitogen-activated protein kinase kinase kinase 9 | P80192 | |
| Others | 85 % | Serine/threonine-protein kinase MRCK-A | Q5VT25 | |
| Others | 95 % | Muscle, skeletal receptor tyrosine protein kinase | O15146 | |
| Others | 104 % | Serine/threonine-protein kinase Nek11 | Q8NG66 | |
| Others | 89 % | Tyrosine-protein kinase BMX | P51813 | |
| Others | 79 % | Tyrosine-protein kinase BMX | P51813 | |
| Others | 99 % | Serine/threonine-protein kinase Chk1 | O14757 | |
| Others | 55 % | CaM kinase II beta | Q13554 | |
| Others | 104 % | Epidermal growth factor receptor erbB1 | P00533 | |
| Others | 96 % | Receptor protein-tyrosine kinase erbB-4 | Q15303 | |
| Others | 79 % | Receptor protein-tyrosine kinase erbB-4 | Q15303 | |
| Others | 96 % | Vascular endothelial growth factor receptor 1 | P17948 | |
| Others | 102 % | Homeodomain-interacting protein kinase 2 | Q9H2X6 | |
| Others | 80 % | Tyrosine-protein kinase JAK2 | O60674 | |
| Others | 104 % | MAP kinase ERK1 | P27361 | |
| Others | 84 % | Serine/threonine-protein kinase MRCK-A | Q5VT25 | |
| Others | 113 % | Serine/threonine-protein kinase Nek11 | Q8NG66 | |
| Others | 107 % | NUAK family SNF1-like kinase 1 | O60285 | |
| Others | 47 % | BR serine/threonine-protein kinase 1 | Q8TDC3 | |
| Others | 73 % | Serine/threonine-protein kinase Chk2 | O96017 | |
| Others | 90 % | Serine/threonine-protein kinase Chk2 | O96017 | |
| Others | 101 % | CaM kinase II gamma | Q13555 | |
| Others | 70 % | CaM kinase II gamma | Q13555 | |
| Others | 94 % | Ephrin type-A receptor 1 | P21709 | |
| Others | 106 % | Ephrin type-A receptor 1 | P21709 | |
| Others | 140 % | Focal adhesion kinase 1 | Q05397 | |
| Others | 47 % | Vascular endothelial growth factor receptor 1 | P17948 | |
| Others | 92 % | Tyrosine-protein kinase receptor FLT3 | P36888 | |
| Others | 86 % | Homeodomain-interacting protein kinase 2 | Q9H2X6 | |
| Others | 101 % | Homeodomain-interacting protein kinase 3 | Q9H422 | |
| Others | 121 % | Tyrosine-protein kinase JAK2 | O60674 | |
| Others | 91 % | Tyrosine-protein kinase JAK3 | P52333 | |
| Others | 81 % | MAP kinase ERK1 | P27361 | |
| Others | 112 % | MAP kinase ERK2 | P28482 | |
| Others | 90 % | Serine/threonine-protein kinase MRCK beta | Q9Y5S2 | |
| Others | 81 % | Serine/threonine-protein kinase MRCK beta | Q9Y5S2 | |
| Others | 76 % | Serine/threonine-protein kinase NEK2 | P51955 | |
| Others | 68 % | Serine/threonine-protein kinase NEK2 | P51955 | |
| Others | 94 % | NUAK family SNF1-like kinase 1 | O60285 | |
| Others | 117 % | Mitogen-activated protein kinase kinase kinase 5 | Q99683 | |
| Others | 48 % | BR serine/threonine-protein kinase 1 | Q8TDC3 | |
| Others | 108 % | BR serine/threonine-protein kinase 2 | Q8IWQ3 | |
| Others | 80 % | Casein kinase I gamma 1 | Q9HCP0 | |
| Others | 108 % | CaM kinase II delta | Q13557 | |
| Others | 115 % | Ephrin type-A receptor 2 | P29317 | |
| Others | 93 % | Focal adhesion kinase 1 | Q05397 | |
| Others | 85 % | Fibroblast growth factor receptor 1 | P11362 | |
| Others | 75 % | Tyrosine-protein kinase receptor FLT3 | P36888 | |
| Others | 93 % | Homeodomain-interacting protein kinase 3 | Q9H422 | |
| Others | 67 % | Tyrosine-protein kinase JAK3 | P52333 | |
| Others | 97 % | MAP kinase ERK2 | P28482 | |
| Others | 130 % | Ribosomal protein S6 kinase alpha 5 | O75582 | |
| Others | 110 % | Serine/threonine-protein kinase Nek3 | P51956 | |
| Others | 107 % | Mitogen-activated protein kinase kinase kinase 5 | Q99683 | |
| Others | 67 % | BR serine/threonine-protein kinase 2 | Q8IWQ3 | |
| Others | 71 % | Casein kinase I gamma 1 | Q9HCP0 | |
| Others | 92 % | Casein kinase I gamma 2 | P78368 | |
| Others | 85 % | CaM kinase II delta | Q13557 | |
| Others | 114 % | CaM kinase IV | Q16566 | |
| Others | 100 % | Ephrin type-A receptor 2 | P29317 | |
| Others | 115 % | Ephrin type-A receptor 3 | P29320 | |
| Others | 44 % | Fibroblast growth factor receptor 1 | P11362 | |
| Others | 85 % | Vascular endothelial growth factor receptor 3 | P35916 | |
| Others | 62 % | Vascular endothelial growth factor receptor 3 | P35916 | |
| Others | 109 % | Serine/threonine-protein kinase haspin | Q8TF76 | |
| Others | 69 % | Serine/threonine-protein kinase haspin | Q8TF76 | |
| Others | 100 % | c-Jun N-terminal kinase 1 | P45983 | |
| Others | 64 % | c-Jun N-terminal kinase 1 | P45983 | |
| Others | 94 % | MAP kinase-activated protein kinase 2 | P49137 | |
| Others | 94 % | MAP kinase-activated protein kinase 2 | P49137 | |
| Others | 112 % | Ribosomal protein S6 kinase alpha 5 | O75582 | |
| Others | 105 % | Ribosomal protein S6 kinase alpha 4 | O75676 | |
| Others | 60 % | Serine/threonine-protein kinase Nek3 | P51956 | |
| Others | 98 % | Serine/threonine-protein kinase NEK6 | Q9HC98 | |
| Others | 85 % | Tyrosine-protein kinase ABL | P00519 | |
| Others | 97 % | Tyrosine-protein kinase ABL | P00519 | |
| Others | 87 % | Casein kinase I gamma 2 | P78368 | |
| Others | 69 % | CaM kinase IV | Q16566 | |
| Others | 92 % | Ephrin type-A receptor 3 | P29320 | |
| Others | 105 % | Fibroblast growth factor receptor 2 | P21802 | |
| Others | 98 % | Fibroblast growth factor receptor 2 | P21802 | |
| Others | 87 % | Macrophage colony stimulating factor receptor | P07333 | |
| Others | 92 % | Tyrosine-protein kinase HCK | P08631 | |
| Others | 82 % | Insulin-like growth factor I receptor | P08069 | |
| Others | 112 % | c-Jun N-terminal kinase 2 | P45984 | |
| Others | 99 % | MAP kinase-activated protein kinase 3 | Q16644 | |
| Others | 94 % | Ribosomal protein S6 kinase alpha 4 | O75676 | |
| Others | 68 % | Serine/threonine-protein kinase NEK6 | Q9HC98 | |
| Others | 92 % | Tyrosine-protein kinase ABL2 | P42684 | |
| Others | 101 % | Casein kinase I isoform gamma-3 | Q9Y6M4 | |
| Others | 72 % | Casein kinase I isoform gamma-3 | Q9Y6M4 | |
| Others | 106 % | CaM kinase I delta | Q8IU85 | |
| Others | 75 % | CaM kinase I delta | Q8IU85 | |
| Others | 113 % | Ephrin type-A receptor 4 | P54764 | |
| Others | 102 % | Ephrin type-A receptor 4 | P54764 | |
| Others | 102 % | Fibroblast growth factor receptor 3 | P22607 | |
| Others | 74 % | Macrophage colony stimulating factor receptor | P07333 | |
| Others | 92 % | Tyrosine-protein kinase FYN | P06241 | |
| Others | 60 % | Tyrosine-protein kinase HCK | P08631 | |
| Others | 95 % | Tyrosine-protein kinase HCK | P08631 | |
| Others | 97 % | Inhibitor of nuclear factor kappa B kinase alpha subunit | O15111 | |
| Others | 92 % | c-Jun N-terminal kinase 2 | P45984 | |
| Others | 81 % | c-Jun N-terminal kinase 3 | P53779 | |
| Others | 53 % | MAP kinase-activated protein kinase 3 | Q16644 | |
| Others | 98 % | Serine/threonine-protein kinase MARK1 | Q9P0L2 | |
| Others | 98 % | cAMP-dependent protein kinase alpha-catalytic subunit | P17612 | |
| Others | 90 % | Protein kinase C theta | Q04759 | |
| Others | 88 % | Serine/threonine-protein kinase PIM2 | Q9P1W9 | |
| Others | 100 % | Serine/threonine-protein kinase PIM3 | Q86V86 | |
| Others | 79 % | Tyrosine-protein kinase receptor TYRO3 | Q06418 | |
| Others | 108 % | Ribosomal protein S6 kinase alpha 1 | Q15418 | |
| Others | 97 % | Serine/threonine-protein kinase SIK1 | P57059 | |
| Others | 92 % | Serine/threonine-protein kinase tousled-like 2 | Q86UE8 | |
| Others | 117 % | Serine/threonine-protein kinase WNK3 | Q9BYP7 | |
| Others | 84 % | Serine/threonine-protein kinase WNK3 | Q9BYP7 | |
| Others | 73 % | cAMP-dependent protein kinase alpha-catalytic subunit | P17612 | |
| Others | 98 % | Serine/threonine-protein kinase AKT | P31749 | |
| Others | 66 % | Protein kinase C theta | Q04759 | |
| Others | 98 % | Protein kinase C iota | P41743 | |
| Others | 95 % | Serine/threonine-protein kinase PIM3 | Q86V86 | |
| Others | 92 % | Ribosomal protein S6 kinase alpha 1 | Q15418 | |
| Others | 107 % | Serine/threonine-protein kinase SRPK1 | Q96SB4 | |
| Others | 98 % | Serine/threonine-protein kinase SRPK1 | Q96SB4 | |
| Others | 101 % | Testis-specific serine/threonine-protein kinase 1 | Q9BXA7 | |
| Others | 105 % | Testis-specific serine/threonine-protein kinase 1 | Q9BXA7 | |
| Others | 105 % | Tyrosine-protein kinase YES | P07947 | |
| Others | 110 % | Serine/threonine-protein kinase AKT | P31749 | |
| Others | 81 % | Protein kinase C iota | P41743 | |
| Others | 108 % | Serine/threonine-protein kinase PLK1 | P53350 | |
| Others | 75 % | Serine/threonine-protein kinase PLK1 | P53350 | |
| Others | 115 % | Ribosomal protein S6 kinase alpha 3 | P51812 | |
| Others | 91 % | Ribosomal protein S6 kinase alpha 3 | P51812 | |
| Others | 96 % | Serine/threonine-protein kinase SRPK2 | P78362 | |
| Others | 102 % | Testis-specific serine/threonine-protein kinase 2 | Q96PF2 | |
| Others | 84 % | Tyrosine-protein kinase YES | P07947 | |
| Others | 119 % | Tyrosine-protein kinase ZAP-70 | P43403 | |
| Others | 90 % | Serine/threonine-protein kinase AKT2 | P31751 | |
| Others | 53 % | Serine/threonine-protein kinase AKT2 | P31751 | |
| Others | 110 % | Protein kinase C mu | Q15139 | |
| Others | 61 % | Protein kinase C mu | Q15139 | |
| Others | 96 % | Serine/threonine-protein kinase PLK3 | Q9H4B4 | |
| Others | 104 % | Ribosomal protein S6 kinase alpha 2 | Q15349 | |
| Others | 96 % | Serine/threonine-protein kinase SRPK2 | P78362 | |
| Others | 97 % | Serine/threonine-protein kinase 33 | Q9BYT3 | |
| Others | 108 % | Testis-specific serine/threonine-protein kinase 2 | Q96PF2 | |
| Others | 86 % | Tyrosine-protein kinase TEC | P42680 | |
| Others | 95 % | Tyrosine-protein kinase ZAP-70 | P43403 | |
| Others | 82 % | Serine/threonine-protein kinase AKT3 | Q9Y243 | |
| Others | 101 % | Serine/threonine-protein kinase D2 | Q9BZL6 | |
| Others | 77 % | Serine/threonine-protein kinase PLK3 | Q9H4B4 | |
| Others | 104 % | Serine/threonine-protein kinase PRKX | P51817 | |
| Others | 93 % | Ribosomal protein S6 kinase alpha 2 | Q15349 | |
| Others | 97 % | Ribosomal protein S6 kinase alpha 6 | Q9UK32 | |
| Others | 92 % | Serine/threonine-protein kinase 33 | Q9BYT3 | |
| Others | 66 % | Tyrosine-protein kinase TEC | P42680 | |
| Others | 94 % | Death-associated protein kinase 3 | O43293 | |
| Others | 115 % | Death-associated protein kinase 3 | O43293 | |
| Others | 103 % | Serine/threonine-protein kinase PAK 4 | O96013 | |
| Others | 63 % | Serine/threonine-protein kinase AKT3 | Q9Y243 | |
| Others | 110 % | Protein kinase C alpha | P17252 | |
| Others | 114 % | Serine/threonine-protein kinase D2 | Q9BZL6 | |
| Others | 81 % | Serine/threonine-protein kinase PRKX | P51817 | |
| Others | 103 % | Ribosomal protein S6 kinase alpha 6 | Q9UK32 | |
| Others | 103 % | Serine/threonine-protein kinase PLK2 | Q9NYY3 | |
| Others | 71 % | Serine/threonine-protein kinase PLK2 | Q9NYY3 | |
| Others | 12 % | Tyrosine-protein kinase TIE-2 | Q02763 | |
| Others | 3 % | Tyrosine-protein kinase TIE-2 | Q02763 | |
| Others | 101 % | Serine/threonine-protein kinase RAF | P04049 | |
| Others | 100 % | Serine/threonine-protein kinase PAK 4 | O96013 | |
| Others | 101 % | Serine/threonine-protein kinase PAK7 | Q9P286 | |
| Others | 100 % | Protein kinase C alpha | P17252 | |
| Others | 110 % | cGMP-dependent protein kinase 1 beta | Q13976 | |
| Others | 92 % | cGMP-dependent protein kinase 1 beta | Q13976 | |
| Others | 133 % | Protein tyrosine kinase 2 beta | Q14289 | |
| Others | 89 % | Protein tyrosine kinase 2 beta | Q14289 | |
| Others | 106 % | MAP kinase p38 alpha | Q16539 | |
| Others | 115 % | MAP kinase p38 alpha | Q16539 | |
| Others | 132 % | Tyrosine-protein kinase SYK | P43405 | |
| Others | 113 % | Nerve growth factor receptor Trk-A | P04629 | |
| Others | 100 % | Serine/threonine-protein kinase RAF | P04049 | |
| Others | 123 % | Stem cell growth factor receptor | P10721 | |
| Others | 87 % | Serine/threonine-protein kinase PAK7 | Q9P286 | |
| Others | 110 % | Protein kinase C beta | P05771 | |
| Others | 98 % | Protein kinase C beta | P05771 | |
| Others | 92 % | cGMP-dependent protein kinase 1 beta | Q13976 | |
| Others | 96 % | Serine/threonine-protein kinase RIPK2 | O43353 | |
| Others | 107 % | MAP kinase p38 beta | Q15759 | |
| Others | 82 % | Tyrosine-protein kinase SYK | P43405 | |
| Others | 92 % | Mitogen-activated protein kinase kinase kinase 7 | O43318 | |
| Others | 108 % | Nerve growth factor receptor Trk-A | P04629 | |
| Others | 106 % | Neurotrophic tyrosine kinase receptor type 2 | Q16620 | |
| Others | 95 % | Stem cell growth factor receptor | P10721 | |
| Others | 99 % | Serine/threonine-protein kinase PAK6 | Q9NQU5 | |
| Others | 61 % | Serine/threonine-protein kinase PAK6 | Q9NQU5 | |
| Others | 87 % | Protein kinase C beta | P05771 | |
| Others | 87 % | cGMP-dependent protein kinase 1 beta | Q13976 | |
| Others | 84 % | MAP kinase-activated protein kinase 5 | Q8IW41 | |
| Others | 88 % | Serine/threonine-protein kinase RIPK2 | O43353 | |
| Others | 110 % | Rho-associated protein kinase 1 | Q13464 | |
| Others | 105 % | MAP kinase p38 beta | Q15759 | |
| Others | 105 % | MAP kinase p38 gamma | P53778 | |
| Others | 94 % | Mitogen-activated protein kinase kinase kinase 7 | O43318 | |
| Others | 81 % | Neurotrophic tyrosine kinase receptor type 2 | Q16620 | |
| Others | 74 % | Tyrosine-protein kinase SRC | P12931 | |
| Others | 69 % | Tyrosine-protein kinase SRC | P12931 | |
| Others | 90 % | MAP/microtubule affinity-regulating kinase 2 | Q7KZI7 | |
| Others | 103 % | Protein kinase C beta | P05771 | |
| Others | 97 % | Protein kinase C gamma | P05129 | |
| Others | 52 % | MAP kinase-activated protein kinase 5 | Q8IW41 | |
| Others | 120 % | Rho-associated protein kinase 1 | Q13464 | |
| Others | 94 % | MAP kinase p38 gamma | P53778 | |
| Others | 107 % | Serine/threonine-protein kinase TAO1 | Q7L7X3 | |
| Others | 87 % | Serine/threonine-protein kinase TAO1 | Q7L7X3 | |
| Others | 94 % | Tyrosine-protein kinase TXK | P42681 | |
| Others | 59 % | Tyrosine-protein kinase TXK | P42681 | |
| Others | 101 % | Serine/threonine-protein kinase EEF2K | O00418 | |
| Others | 108 % | MAP/microtubule affinity-regulating kinase 2 | Q7KZI7 | |
| Others | 101 % | Protein kinase C gamma | P05129 | |
| Others | 101 % | Protein kinase N2 | Q16513 | |
| Others | 92 % | Protein kinase N2 | Q16513 | |
| Others | 96 % | Rho-associated protein kinase 2 | O75116 | |
| Others | 82 % | Rho-associated protein kinase 2 | O75116 | |
| Others | 112 % | MAP kinase p38 delta | O15264 | |
| Others | 105 % | Serine/threonine-protein kinase TAO2 | Q9UL54 | |
| Others | 104 % | Serine/threonine-protein kinase ULK2 | Q8IYT8 | |
| Others | 94 % | Serine/threonine-protein kinase EEF2K | O00418 | |
| Others | 107 % | Serine/threonine-protein kinase mTOR | P42345 | |
| Others | 70 % | PAS domain-containing serine/threonine-protein kinase | Q96RG2 | |
| Others | 61 % | PAS domain-containing serine/threonine-protein kinase | Q96RG2 | |
| Others | 104 % | Protein kinase C delta | Q05655 | |
| Others | 103 % | Protein kinase C delta | Q05655 | |
| Others | 94 % | Tyrosine-protein kinase FRK | P42685 | |
| Others | 86 % | Tyrosine-protein kinase receptor RET | P07949 | |
| Others | 97 % | MAP kinase p38 delta | O15264 | |
| Others | 102 % | Serine/threonine-protein kinase Sgk1 | O00141 | |
| Others | 93 % | Serine/threonine-protein kinase TAO2 | Q9UL54 | |
| Others | 99 % | Serine/threonine-protein kinase TAO3 | Q9H2K8 | |
| Others | 94 % | Serine/threonine-protein kinase ULK2 | Q8IYT8 | |
| Others | 107 % | Serine/threonine-protein kinase ULK3 | Q6PHR2 | |
| Others | 88 % | Serine/threonine-protein kinase mTOR | P42345 | |
| Others | 113 % | Platelet-derived growth factor receptor alpha | P16234 | |
| Others | 88 % | Protein kinase C epsilon | Q02156 | |
| Others | 69 % | Tyrosine-protein kinase FRK | P42685 | |
| Others | 111 % | Phosphorylase kinase gamma subunit 2 | P15735 | |
| Others | 106 % | Tyrosine-protein kinase receptor RET | P07949 | |
| Others | 86 % | Macrophage-stimulating protein receptor | Q04912 | |
| Others | 85 % | Serine/threonine-protein kinase Sgk1 | O00141 | |
| Others | 90 % | Serine/threonine-protein kinase TAO3 | Q9H2K8 | |
| Others | 96 % | Serine/threonine-protein kinase ULK3 | Q6PHR2 | |
| Others | 103 % | Platelet-derived growth factor receptor alpha | P16234 | |
| Others | 108 % | Platelet-derived growth factor receptor beta | P09619 | |
| Others | 78 % | Protein kinase C epsilon | Q02156 | |
| Others | 103 % | Protein kinase C zeta | Q05513 | |
| Others | 96 % | Phosphorylase kinase gamma subunit 2 | P15735 | |
| Others | 75 % | Macrophage-stimulating protein receptor | Q04912 | |
| Others | 130 % | Serine/threonine-protein kinase Sgk2 | Q9HBY8 | |
| Others | 65 % | Serine/threonine-protein kinase Sgk2 | Q9HBY8 | |
| Others | 81 % | Serine/threonine-protein kinase TBK1 | Q9UHD2 | |
| Others | 65 % | Serine/threonine-protein kinase TBK1 | Q9UHD2 | |
| Others | 110 % | Serine/threonine-protein kinase VRK2 | Q86Y07 | |
| Others | 91 % | Serine/threonine-protein kinase VRK2 | Q86Y07 | |
| Others | 130 % | Ribosomal protein S6 kinase 1 | P23443 | |
| Others | 108 % | Platelet-derived growth factor receptor beta | P09619 | |
| Others | 75 % | Protein kinase C zeta | Q05513 | |
| Others | 93 % | Serine/threonine-protein kinase PIM1 | P11309 | |
| Others | 93 % | Serine/threonine-protein kinase PIM1 | P11309 | |
| Others | 97 % | Proto-oncogene tyrosine-protein kinase ROS | P08922 | |
| Others | 104 % | Proto-oncogene tyrosine-protein kinase ROS | P08922 | |
| Others | 102 % | Serine/threonine-protein kinase Sgk3 | Q96BR1 | |
| Others | 82 % | TGF-beta receptor type I | P36897 | |
| Others | 114 % | Serine/threonine-protein kinase WNK2 | Q9Y3S1 | |
| Others | 63 % | Ribosomal protein S6 kinase 1 | P23443 | |
| Others | 106 % | 3-phosphoinositide dependent protein kinase-1 | O15530 | |
| Others | 110 % | 3-phosphoinositide dependent protein kinase-1 | O15530 | |
| Others | 112 % | Protein kinase C eta | P24723 | |
| Others | 86 % | Protein kinase C eta | P24723 | |
| Others | 86 % | Serine/threonine-protein kinase PIM2 | Q9P1W9 | |
| Others | 89 % | Tyrosine-protein kinase receptor TYRO3 | Q06418 | |
| Others | 79 % | Serine/threonine-protein kinase Sgk3 | Q96BR1 | |
| Others | 92 % | Serine/threonine-protein kinase SIK1 | P57059 | |
| Others | 89 % | TGF-beta receptor type I | P36897 | |
| Others | 95 % | Serine/threonine-protein kinase tousled-like 2 | Q86UE8 | |
| Others | 76 % | Serine/threonine-protein kinase WNK2 | Q9Y3S1 | |
| IC50 | 1280000 nM | DOPA decarboxylase | P20711 | |
